[Ip-health] Fwd: TAGline: Intellectual Property and Access

Suraj Madoori suraj.madoori at treatmentactiongroup.org
Tue Dec 11 09:56:51 PST 2018


*Apologies for duplicates/cross-postings*
<https://default.salsalabs.org/Tbce4c706-f018-4b29-a7ee-aa97a065fb4b/4993b156-c056-4610-b590-a4988589982e>

*Bringing Down the House on Intellectual Property and Access*

As the Trump administration makes noise about the high price of
pharmaceuticals while doubling down on its commitment to "protect the
engine of American ingenuity," this *issue of TAGline
<https://default.salsalabs.org/T3a11c03a-0f4b-45db-b40a-17753dacae19/4993b156-c056-4610-b590-a4988589982e>*
dives deep into the rhetoric and realities of intellectual property  (IP)
protections  and  the current wave of political shenanigans on critical
drugs, surfacing the fundamental lies and vested interests that deny
medication to those in need in the United States and around the world.

In this *issue of TAGline
<https://default.salsalabs.org/T9f16d1d9-8834-4aed-9231-fbd7446114d8/4993b156-c056-4610-b590-a4988589982e>*
:

*Whose Intellect? Whose Property? A Blueprint for Bringing Down the Pharma
IP House of Cards
<https://default.salsalabs.org/T364fdb5f-8945-45de-866d-2c01fedf85fe/4993b156-c056-4610-b590-a4988589982e>*
By JD Davids, TAGline Guest Editor and Suraj Madoori, U.S. and Global
Health Policy Director, TAG

*Beyond Declarations: Lessons from the UN High-Level Meeting on TB on
Building and Transforming Political Will into Real Access to Medicines*
<https://default.salsalabs.org/T2c191f2b-2b58-4d00-adf5-8d67dfb6f872/4993b156-c056-4610-b590-a4988589982e>
By Khairunisa Suleiman, Technical Co-Lead, Global TB CAB and Suraj Madoori,
U.S. and Global Health Policy Director, TAG

*Fierce Activism from the Global Access to Medicines (A2M) Movement:
Reflections on Recent Sucess*
<https://default.salsalabs.org/T1ad1a816-fb2e-4d93-9124-7a4f96dc0dc1/4993b156-c056-4610-b590-a4988589982e>
By Bryn Gay, HCV Project Director, TAG

*Getting Rid of the Boogeyman: The Reality of Prescription Drug Price
Controls*
<https://default.salsalabs.org/T0f3d9ae1-db60-488c-b336-60619baff11a/4993b156-c056-4610-b590-a4988589982e>
By Annette Gaudino, HCV/HIV Project Co-Director, TAG

*Keeping an Eye on Intellectual Property Issues in HIV Cure and Prevention
Research*
<https://default.salsalabs.org/T0fb4d42d-24e5-4d37-bccb-8e6ef3ff04a9/4993b156-c056-4610-b590-a4988589982e>
By Richard Jefferys, Basic Science, Vaccines, and Cure Project Director, TAG

*Pharma Lies, People Die: Myth-Busting Fact Sheet on Medicine Development
and Pricing*
<https://default.salsalabs.org/T50ca6b24-fd77-48c4-9a9f-69f6ccf30ef6/4993b156-c056-4610-b590-a4988589982e>
By Bryn Gay, HCV Project Director, TAG and Claudine Guerra, CUNY

*A Pharma View on Delinkage and New Models for Biomedical Innovation: An
Interview with Marc Destito from Otsuka Pharmaceutical*
<https://default.salsalabs.org/T5fec9743-8cf6-4dbf-8f8a-de919026cc51/4993b156-c056-4610-b590-a4988589982e>
by Mike Frick and Lindsay McKenna, TB Project Co-Directors, TAG

We're sure you'll like reading this *TAGline* as much as we enjoyed writing
it and putting it together.
<https://default.salsalabs.org/T373869df-3383-4751-b146-e9e8babc99e9/4993b156-c056-4610-b590-a4988589982e>

*Contact Us:* Treatment Action Group, 90 Broad Street, Suite 2503, New
York, New York 10004, 212-253-7922.
Communications at treatmentactiongroup.org.
<https://default.salsalabs.org/T32575170-9b8f-4e2b-9db5-1fcb936de928/4993b156-c056-4610-b590-a4988589982e>
This year marks TAG's 26th year fighting for life-saving medications for
people living with, and at risk for, HIV, TB, and HCV. Please consider
supporting this work by making a *donation*
<https://default.salsalabs.org/Tf699682d-c55a-4fcb-ad7c-03da51640460/4993b156-c056-4610-b590-a4988589982e>
today.
<https://default.salsalabs.org/T2984cfa2-14b6-4bcc-94f3-18afaf6a933c/4993b156-c056-4610-b590-a4988589982e>



-- 

*Suraj Madoori*
U.S. and Global Health Policy Director
*Treatment Action Group*
mobile: +1.917.530.5996
www.treatmentactiongroup.org


*Treatment Action Group *
90 Broad St, Suite 2503
New York, NY 10004 USA
tel: +1.212.253.7922
fax: +1.212.253.7923
www.treatmentactiongroup.org


More information about the Ip-health mailing list